首页> 外文期刊>Nature and Science of Sleep >A novel implantable device for a minimally invasive surgical treatment of obstructive sleep apnea: design and preclinical safety assessment
【24h】

A novel implantable device for a minimally invasive surgical treatment of obstructive sleep apnea: design and preclinical safety assessment

机译:一种用于微创外科手术治疗阻塞性睡眠呼吸暂停的新型可植入设备:设计和临床前安全性评估

获取原文
       

摘要

Background: In obstructive sleep apnea (OSA), occlusion of the upper airway by soft tissue causes intermittent hypoxemia and can have serious sequelae. A novel implantable medical device for OSA is composed of a linear silicone elastic element held in an extended state by a bioabsorbable external sheath. The implant is delivered to the tongue base or soft palate via a minimally invasive approach. Normal tissue healing anchors the device at the attachment points before the bioabsorbable material dissolves and the elastic element contracts to stabilize the surrounding tissue. Methods: Device prototypes were evaluated in multiple investigations: 1) a finite elements analysis model simulated the movement of the tongue base during sleep with and without the implant; 2) dynamic mechanical testing simulated 10?years’ normal use; 3) cadaveric implantations were conducted; 4) an ovine study in which implants of varying design were evaluated via gross pathology and histological assessment; and 5) a canine study in which implants of varying design in the tongue base and soft palate were evaluated via gross pathology and histological assessment. Results: 1) The implant was capable of reducing ~95% of tongue base movement during simulated sleep; 2) implants remained intact throughout the testing with no evidence of creep fatigue or change in dynamic modulus; 3) the device could be reliably deployed in the desired placement locations and was appropriate for various anatomies; and 4) all implants were well tolerated through 1?year, with minimal inflammatory responses. Conclusion: This new minimally invasive device for OSA has been demonstrated, through various bench and animal testing, to be safe, well tolerated, suitable for long-term use, and to function as intended. No adverse health consequences were observed in the animals, and histological evaluation indicated good healing. This study establishes proof of concept and supports human trials.
机译:背景:在阻塞性睡眠呼吸暂停(OSA)中,软组织阻塞上呼吸道会导致间歇性低氧血症,并可能导致严重的后遗症。用于OSA的新型可植入医疗装置由线性硅酮弹性元件组成,该弹性元件通过可生物吸收的外部护套保持伸展状态。植入物通过微创方法递送至舌根或软soft。正常的组织愈合会在生物可吸收材料溶解和弹性元件收缩以稳定周围组织之前,将设备固定在连接点上。方法:通过多次调查评估了设备原型:1)有限元分析模型模拟了有或没有植入物的睡眠过程中舌根的运动; 2)动态机械测试模拟正常使用10年; 3)进行尸体植入; 4)一项绵羊研究,其中通过总体病理学和组织学评估对不同设计的植入物进行了评估; 5)一项犬科研究,其中通过总体病理学和组织学评估对舌根和软pa不同设计的植入物进行评估。结果:1)植入物能够在模拟睡眠中减少约95%的舌根运动; 2)在整个测试过程中,植入物保持完好无损,没有蠕变疲劳或动态模量变化的迹象; 3)该设备可以可靠地部署在所需的放置位置,并且适用于各种解剖结构; 4)所有植入物在1年内都具有良好的耐受性,炎症反应最小。结论:通过各种实验台和动物试验,已经证明了这种用于OSA的新型微创设备是安全,耐受性良好,适合长期使用并可以正常使用的。在动物中未观察到不利的健康后果,并且组织学评估表明良好的愈合。这项研究建立了概念证明并支持人体试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号